|Last Price$0.08||Day Change (%)-50.00%|
|Open Price$0.11||Day Change ($)-0.08|
|Day Range0.06–0.11||52-Week Range0.06–1.00|
As of Tue 3/3/2015 4:45:00 PM | USD
FDA Warns on Low-Testosterone Drugs -- Update
Actavis Receives Final Approval for Generic Version of Subutex®
Actavis to Divest Pharmatech to TPG
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.